Novozymes surges yet again on Bioenergy

The Danish enzyme producer notes ongoing growth within several business areas, with the Bioenergy unit showing particularly strong 2022 performance. 
Photo: Novozymes/pr
Photo: Novozymes/pr
BY ANNE FILBERT, TRANSLATED BY DANIEL FRANK CHRISTENSEN

Novozymes reflects back on its fiscal 2022 as one of company’s better years. The Danish enzyme producer closes the period reporting full-year revenue of DKK 17.6bn (EUR 2.37bn). For comparison, the top-line post for 2021 totaled DKK 15bn.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading